Evidence map›Paper›PMID 42575090›Full record

ArticleStructure (London, England : 1993)2026

Conformational signatures of native ligand and pharmacochaperone binding in rhodopsin.

Zaiddodine Pashandi, Joseph Thomas Ortega, Masaru Miyagi, Marcin Golczak, Beata Jastrzebska

Abstract read
In one paragraph

Article in Structure (London, England : 1993), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Zaiddodine PashandiDepartment of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA.
Joseph Thomas OrtegaDepartment of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA.
Masaru MiyagiDepartment of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA; Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA.
Marcin GolczakDepartment of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA; Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA.
Beata JastrzebskaDepartment of Pharmacology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA; Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA. Electronic address: bxj27@case.edu.

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
Regulation of vitamin A metabolism in the eyeR01EY023948 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI GOLCZAK, MARCIN BERNARD · 2014 to 2023
$3.8M
Novel neuroprotective activities of flavonoids against retinal degenerative diseasesR01EY032874 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI JASTRZEBSKA, BEATA · 2022 to 2025
$1.9M
High-End Instrumentation (HEI) Grant Program (S10)S10OD023436 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2017 to 2017
$873k
NEI NIH HHS P30 EY011373NEI NIH HHS R01 EY023948NEI NIH HHS R01 EY032874NIH HHS S10 OD023436
6 · The paper itself

Abstract

Misfolding often underlies rhodopsin-linked retinitis pigmentosa, and small-molecule pharmacochaperones represent a promising therapeutic strategy. However, the mechanisms by which these compounds stabilize rhodopsin remain incompletely understood. We combine amide- and histidine-specific hydrogen-deuterium exchange (HDX) mass spectrometry, protein structure network analysis, molecular docking, and functional spectroscopy to define ligand-induced conformational signatures in rhodopsin elicited by quercetin, myricetin, and chromenone, and compare them with those of native chromophore. Binding of 11-cis-retinal to opsin produces a benchmark orthosteric signature characterized by backbone protection across TM4-TM7, suppression of EX1-like exchange at TM1 and TM4 N-termini, and reframing of residue interaction networks. All three non-retinoid ligands induce partially overlapping HDX footprints consistent with interaction within the orthosteric site, but with ligand-specific differences. Quercetin most closely resembles the 11-cis-retinal pattern, whereas myricetin and chromenone show reduced and redistributed protection. These findings define structural determinants of ligand-induced opsin stabilization and provide a framework for optimizing small-molecule opsin stabilizers.

Indexed as

FlavonoidsRhodopsinAnimalsBinding SitesLigandsMolecular Docking SimulationProtein BindingProtein ConformationQuercetinRetinaldehydeFlavonoidsLigandsmyricetinQuercetinRetinaldehydeRhodopsinallosteric modulationGPCR rhodopsinhydrogen-deuterium exchange mass spectrometry: HDX-MSnon-retinoid ligandspharmacochaperones

Identifiers

PMID42575090
PMCPMC13464442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.